Empower Clinics Inc. (EPWCF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -1.08 Million USD | 99.9% |
| 2021 | -30.73 Million USD | -43.24% |
| 2020 | -16.83 Million USD | -12.53% |
| 2019 | -3.7 Million USD | 14.91% |
| 2018 | -3.13 Million USD | -2122.83% |
| 2017 | -2.23 Million USD | 52.96% |
| 2016 | -212.41 Thousand USD | 25.17% |
| 2015 | -247.75 Thousand USD | 76.35% |
| 2014 | 743.77 Thousand USD | -2486.84% |
| 2013 | -5.38 Million USD | 105.56% |
| 2012 | -4.34 Million USD | 84.1% |
| 2011 | -9.65 Million USD | -324.62% |
| 2010 | -2.01 Million USD | -46.46% |
| 2009 | -1.5 Million USD | -385.07% |
| 2008 | -268.32 Thousand USD | -214.63% |
| 2007 | - USD | -35.66% |
| 2006 | -36.17 Thousand USD | -335.31% |
| 2005 | -19.34 Thousand USD | -293.24% |
| 2004 | -66.52 Thousand USD | 94.63% |
| 2003 | -72.72 Thousand USD | 47.43% |
| 2002 | -138.34 Thousand USD | 84.76% |
| 2001 | -907.9 Thousand USD | 18.95% |
| 2000 | -1.12 Million USD | -931.18% |
| 1999 | -108.63 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | - USD | 100.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q1 | -2.73 Million USD | -47.77% |
| 2022 FY | - USD | 3.69% |
| 2022 Q4 | -987.15 Thousand USD | -102.84% |
| 2022 Q3 | -486.67 Thousand USD | -235.93% |
| 2022 Q2 | 358.04 Thousand USD | 113.1% |
| 2021 Q1 | -1.21 Million USD | 40.81% |
| 2021 Q4 | -1.84 Million USD | -220.78% |
| 2021 Q3 | -576.71 Thousand USD | 52.1% |
| 2021 Q2 | -1.2 Million USD | 0.73% |
| 2021 FY | - USD | -43.24% |
| 2020 Q3 | -788.79 Thousand USD | -241.18% |
| 2020 Q2 | -231.19 Thousand USD | -59.61% |
| 2020 Q1 | -144.84 Thousand USD | 77.41% |
| 2020 FY | - USD | -12.53% |
| 2020 Q4 | -2.04 Million USD | -159.75% |
| 2019 Q1 | -288.92 Thousand USD | -200.3% |
| 2019 Q2 | -1.3 Million USD | -350.92% |
| 2019 Q3 | -622.98 Thousand USD | 52.18% |
| 2019 Q4 | -641.14 Thousand USD | -2.92% |
| 2019 FY | - USD | 14.91% |
| 2018 FY | - USD | -2122.83% |
| 2018 Q3 | -1.14 Million USD | 8.74% |
| 2018 Q2 | -1.25 Million USD | -3028.33% |
| 2018 Q1 | -40 Thousand USD | -350.0% |
| 2018 Q4 | 288.06 Thousand USD | 125.22% |
| 2017 FY | - USD | 52.96% |
| 2017 Q4 | 16 Thousand USD | 117.02% |
| 2017 Q3 | -94 Thousand USD | -176.47% |
| 2017 Q2 | -34 Thousand USD | -3.03% |
| 2017 Q1 | -33 Thousand USD | 86.64% |
| 2016 Q4 | -247 Thousand USD | -1076.19% |
| 2016 Q2 | -31 Thousand USD | -40.91% |
| 2016 Q1 | -22 Thousand USD | 89.77% |
| 2016 Q3 | -21 Thousand USD | 32.26% |
| 2016 FY | - USD | 25.17% |
| 2015 Q2 | -53 Thousand USD | 42.39% |
| 2015 Q3 | -20 Thousand USD | 62.26% |
| 2015 Q4 | -215 Thousand USD | -975.0% |
| 2015 FY | - USD | 76.35% |
| 2015 Q1 | -92 Thousand USD | 94.31% |
| 2014 Q1 | 4000.00 USD | -99.7% |
| 2014 Q4 | -1.61 Million USD | -2211.43% |
| 2014 Q3 | -70 Thousand USD | 44.88% |
| 2014 Q2 | -127 Thousand USD | -3275.0% |
| 2014 FY | - USD | -2486.84% |
| 2013 Q3 | -726 Thousand USD | -295.69% |
| 2013 Q1 | -846 Thousand USD | -170.56% |
| 2013 Q4 | 1.34 Million USD | 285.4% |
| 2013 FY | - USD | 105.56% |
| 2013 Q2 | 371 Thousand USD | 143.85% |
| 2012 Q3 | -972 Thousand USD | -39.06% |
| 2012 Q4 | 1.19 Million USD | 223.35% |
| 2012 FY | - USD | 84.1% |
| 2012 Q1 | -880 Thousand USD | 45.54% |
| 2012 Q2 | -699 Thousand USD | 20.57% |
| 2011 Q3 | -2.75 Million USD | -34.96% |
| 2011 FY | - USD | -324.62% |
| 2011 Q4 | -1.61 Million USD | 41.32% |
| 2011 Q2 | -2.04 Million USD | -13.15% |
| 2011 Q1 | -1.8 Million USD | -98.48% |
| 2010 Q4 | -908.62 Thousand USD | -101.59% |
| 2010 Q1 | -602.93 Thousand USD | -63.97% |
| 2010 Q2 | -482.62 Thousand USD | 19.95% |
| 2010 FY | - USD | -46.46% |
| 2010 Q3 | -450.72 Thousand USD | 6.61% |
| 2009 Q1 | -37.11 Thousand USD | 41.95% |
| 2009 Q4 | -367.72 Thousand USD | 70.41% |
| 2009 Q3 | -1.24 Million USD | -3039.78% |
| 2009 Q2 | -39.57 Thousand USD | -6.63% |
| 2009 FY | - USD | -385.07% |
| 2008 Q1 | -113.99 Thousand USD | -199.02% |
| 2008 FY | - USD | -214.63% |
| 2008 Q2 | -53.96 Thousand USD | 52.66% |
| 2008 Q4 | -63.94 Thousand USD | 19.16% |
| 2008 Q3 | -79.09 Thousand USD | -46.57% |
| 2007 Q3 | -26.45 Thousand USD | -49.25% |
| 2007 Q1 | -30 Thousand USD | -82.33% |
| 2007 Q4 | -38.12 Thousand USD | -44.1% |
| 2007 FY | - USD | -35.66% |
| 2007 Q2 | -17.72 Thousand USD | 40.92% |
| 2006 FY | - USD | -335.31% |
| 2006 Q4 | -16.45 Thousand USD | 28.83% |
| 2006 Q2 | -21.38 Thousand USD | -4.02% |
| 2006 Q1 | -20.55 Thousand USD | -1069.17% |
| 2006 Q3 | -23.12 Thousand USD | -8.14% |
| 2005 Q1 | -3042.00 USD | 48.63% |
| 2005 Q4 | -1758.00 USD | 73.02% |
| 2005 Q2 | -1554.00 USD | 48.92% |
| 2005 FY | - USD | -293.24% |
| 2005 Q3 | -6515.00 USD | -319.24% |
| 2004 Q3 | -10.21 Thousand USD | -45.79% |
| 2004 Q1 | -6056.00 USD | 43.05% |
| 2004 FY | - USD | 94.63% |
| 2004 Q4 | -5922.00 USD | 42.0% |
| 2004 Q2 | -7003.00 USD | -15.64% |
| 2003 Q2 | -13.76 Thousand USD | -105.27% |
| 2003 Q3 | -5771.00 USD | 58.08% |
| 2003 FY | - USD | 47.43% |
| 2003 Q1 | -25.27 Thousand USD | 1035.47% |
| 2003 Q4 | -10.63 Thousand USD | -84.27% |
| 2002 Q3 | -23.38 Thousand USD | 20.65% |
| 2002 Q2 | -28.3 Thousand USD | 30.77% |
| 2002 Q1 | -40.88 Thousand USD | 12.46% |
| 2002 FY | - USD | 84.76% |
| 2002 Q4 | -27.15 Thousand USD | -24.25% |
| 2001 FY | - USD | 18.95% |
| 2001 Q3 | -45.66 Thousand USD | -23.71% |
| 2001 Q2 | -36.91 Thousand USD | 27.51% |
| 2001 Q1 | -50.92 Thousand USD | 93.42% |
| 2001 Q4 | -46.7 Thousand USD | -2.26% |
| 2000 Q3 | -988.79 Thousand USD | -1193.53% |
| 2000 Q2 | -93.98 Thousand USD | -123.76% |
| 2000 Q1 | -34.16 Thousand USD | -47.44% |
| 2000 Q4 | -774.39 Thousand USD | 21.68% |
| 2000 FY | - USD | -931.18% |
| 1999 Q3 | -70.62 Thousand USD | -7925.0% |
| 1999 Q2 | -880.00 USD | 0.0% |
| 1999 Q4 | -23.17 Thousand USD | 67.19% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 90.092% |
| Arem Pacific Corporation | 36.71 Thousand USD | 3064.126% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | -863.838% |
| BioCorRx Inc. | -2.68 Million USD | 59.452% |
| Bionik Laboratories Corp. | -4.77 Million USD | 77.212% |
| Banyan Corp. | 583.94 Thousand USD | 286.368% |
| Clearday, Inc. | -7.53 Million USD | 85.56% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | 8553.966% |
| Quantum Medical Transport, Inc. | - USD | Infinity% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 50.752% |
| Selectis Health, Inc. | -7.29 Million USD | 85.08% |
| Ethema Health Corporation | 2.07 Million USD | 152.519% |
| HealthLynked Corp. | -2.75 Million USD | 60.431% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 59.001% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | 3872.721% |
| Comjoyful International Company | 167.89 Thousand USD | 748.19% |
| Medical Facilities Corporation | 77.94 Million USD | 101.396% |
| MedSmart Group Inc. | 47.8 Thousand USD | 2376.306% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | -74.591% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 209.434% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | -439.473% |
| PAO Group, Inc. | 292.96 Thousand USD | 471.473% |
| Primemd Inc. | 3.42 Million USD | 131.757% |
| Raffles Medical Group Ltd | 100.7 Million USD | 101.081% |
| Ryman Healthcare Limited | -54.51 Million USD | 98.004% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -25609.402% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 62.399% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | -95.907% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | -2120.978% |
| Veltex Corporation | -938.45 Thousand USD | -15.965% |
| World Financial Holding Group | -28.43 Thousand USD | -3727.925% |
| Xcelerate Inc. | -2.53 Million USD | 57.126% |